NUROFEN PLUS

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

资料单张 资料单张 (PIL)
17-08-2016
产品特点 产品特点 (SPC)
18-08-2016

有效成分:

CODEINE AS HEMIHYDRATE; IBUPROFEN

可用日期:

RECKITT BENCKISER (NEAR EAST) LTD

ATC代码:

M01AE51

药物剂型:

TABLETS

组成:

IBUPROFEN 200 MG; CODEINE AS HEMIHYDRATE 10 MG

给药途径:

PER OS

处方类型:

Not required

厂商:

RECKITT BENCKISER HEALTHCARE INTERNATIONAL LTD, UK

治疗组:

IBUPROFEN, COMBINATIONS

治疗领域:

IBUPROFEN, COMBINATIONS

疗效迹象:

For short term use for the relief of acute (short lasting) moderate pain, such as rheumatic pain (arthritis), muscular pain, backaches, neuralgia, migraine, headache, dental pain and menstrual pain.

授权日期:

2015-01-31

产品特点

                                NUROFEN PLUS Tab 25. 12. 2005, RH
"
ע עבקנ הז ןולע טמרופ
"
רשואו קדבנ ונכותו תואירבה דרשמ י
."
“This leaflet format has been determined by the Ministry of Health
and the content thereof has been
checked and approved.”
NUROFEN
® PLUS
TABLETS
COMPOSITION
Each tablet contains:
_Active Ingredient _
Ibuprofen
200
mg
Codeine phosphate hemihydrate 12.8 mg
(equivalent to codeine 10 mg)
_Other Ingredients _
Cellulose, microcrystalline, sodium starch glycollate (
_from potato starch_
), starch
pregelatinised (
_from maize, potato, or rice starch_
), hypromellose (hydroxypropylmethyl
cellulose), titanium dioxide (E 171), talc
PHARMACOLOGICAL PARTICULARS
_Pharmacodynamic Properties _
Ibuprofen is an analgesic which acts peripherally, inhibiting
prostaglandin synthesis
and the action of chemical mediators of pain. Codeine is a narcotic
analgesic acting
on central opiate receptors, although its pharmacological effects are
thought to be
due largely to its biotransformation to morphine.
The combination of a well tolerated peripheral analgesic with a
centrally acting
analgesic provides optimum pain relief with a lower potential for
producing side-
effects.
_Pharmacokinetic Properties _
The elimination half-life of both ibuprofen and codeine is
approximately three hours,
and both drugs are given three to fours times daily. The combination
of the two
drugs is therefore appropriate from a pharmacokinetic viewpoint; the
tablet exhibits
normal release characteristics for both active substances.
INDICATIONS
For the relief of pain in such conditions as: rheumatic and muscular
pain, backache,
neuralgia, migraine, headache, dental pain, dysmenorrhoea,
feverishness, symptoms
of colds and influenza.
CONTRAINDICATIONS
Known hypersensitivity to the drug or to any ingredient of the
preparation.
Patients with a history of, or existing peptic ulceration.
Patients with severe hepatic failure, severe renal failure, severe
heart failure.
Previous allergic reaction to any other pain reliever / fever re
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 阿拉伯文 04-08-2015
资料单张 资料单张 希伯来文 17-08-2016

查看文件历史